Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01697904 · ClinicalTrials.gov registry record · NA
Trial of a Limited Versus Traditional Oxygen Strategy During Resuscitation in Premature Newborns
A NA study of Oxidative Stress and Prematurity, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT01697904 is a NA study of Oxidative Stress and Prematurity that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 88 participants, roughly in line with the 84-participant average among 36 other Oxidative Stress trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT01697904, a NA study of Oxidative Stress and Prematurity, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
Preterm infants are born with immature lungs and often require help with breathing shortly after birth. This traditionally involves administering 100% oxygen. Unfortunately, delivery of high oxygen concentrations leads to the production of free radicals that can injure many organ systems. Term and near-term newborns deprived of oxygen during or prior to birth respond as well or better to resuscitation with room air (21% oxygen) compared to 100% oxygen. However, a static concentration of 21% oxygen may be inappropriate for preterm infants with lung disease.Purpose of the study is to investigate if preterm neonates where resuscitation is initiated with 21% fiO2 and adjusted to meet transitional goal saturations (Limited oxygen strategy or LOX) would have less oxidative stress as measured by the oxidative balance ratio of biological antioxidant potential/total hydroperoxide compared to infants where resuscitation is initiated with pure oxygen and titrated for targeted saturations of 85-94% (Traditional oxygen strategy or TOX). Secondary outcomes of interest included need for other delivery room resuscitation measures, respiratory support and ventilation/oxygenation status upon neonatal intensive care unit (NICU) admission, survival to hospital discharge, bronchopulmonary dysplasia and other short-term morbidities.
Conditions Studied
Interventions
- PROCEDURE Titration of oxygen during newborn resuscitation in delivery room
Study Locations (1)
Texas
- Parkland Memorial Hospital - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01697904
The ClinicalTrials.gov registry entry for NCT01697904 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 84-participant average among 36 other Oxidative Stress trials with a reported enrollment target. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Oxidative Stress appearing as the primary indexed condition, and to 1 intervention - of which Titration of oxygen during newborn resuscitation in delivery room is the first listed.
NCT01697904 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01697904 about?
NCT01697904 is a clinical study titled "Trial of a Limited Versus Traditional Oxygen Strategy During Resuscitation in Premature Newborns". Preterm infants are born with immature lungs and often require help with breathing shortly after birth. This traditionally involves administering 100% oxygen. Unfortunately, delivery of high oxygen concentrations leads to the production of free radicals that can injure many organ systems. Term and n...
What is the current status of trial NCT01697904?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2010-08. Estimated completion is 2011-01.
What conditions does trial NCT01697904 study?
This clinical trial studies the following conditions: Oxidative Stress, Prematurity.
What interventions are being tested in trial NCT01697904?
The interventions under investigation include: Titration of oxygen during newborn resuscitation in delivery room (PROCEDURE).
Who is sponsoring clinical trial NCT01697904?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01697904 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oxidative Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Impact of Haskap Berries on Recovery From High Intensity Resistance Training
RECRUITING · NA
-
The Effects of Endotracheal Suctioning on Pain and Serum Markers
RECRUITING · NA
-
Targeting Oxidative Stress to Prevent Vascular and Skeletal Muscle Dysfunction During Disuse
RECRUITING · NA
-
Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure
RECRUITING · NA
-
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.